Health News

GALASHIELS & MARLOW, & BIRMINGHAM, United Kingdom--(BUSINESS WIRE)--Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), a Japan-based global specialty pharmaceutical company, and the University Hospitals Birmingham NHS Foundation Trust, today announced new overall survival (OS) insights from the PROCLIPI (PROgnostic Cutaneous Lymphoma International Prognostic Index) Study aligning with previous findings that suggest mogamulizumab may offe...

BOSTON--(BUSINESS WIRE)--PureTech Presents New Phase 2b Analyses Demonstrating Consistent Safety and Efficacy of Deupirfenidone in Older Patients with IPF...

LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced the pricing of an underwritten public offering of 4,196,000 shares of the Company’s Class A common stock (the “Offering”). The shares of Class A common stock are being sold at a public offering price of $7.15 per share, before underwriting discounts and commissions. All of the shares in the Offering are to be sold by the Company. The gross proceeds to Owlet f...

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today announced the pricing of an underwritten public offering of shares of its common stock. Viridian is selling a total of 11,425,000 shares of common stock at a public offering price of $22.00 per share. In addition, Viridian has granted the underwriters a 30-day option to p...

SAN FRANCISCO & LAS VEGAS--(BUSINESS WIRE)--HLTH Booth #3021 — Ambience Healthcare, the leading ambient AI platform for documentation, coding, and clinical workflows, today announced that it has been ranked #1 for improving the clinician experience in KLAS’s Emerging Solutions Top 20 report. Ambience was also ranked #3 in both Improving the Patient Experience and Improving Outcomes. The annual KLAS Emerging Solutions report highlights the most impactful healthcare technology solutions, based on...

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that it has entered into a license and collaboration agreement with Innovent Biologics (HKEX: 01801) for the development, manufacturing and commercialization of two late-stage oncology medicines, IBI363 and IBI343, worldwide outside of Greater China.* IBI363 is being evaluated in non-small cell lung and colorectal cancers and has shown potential efficacy in additional solid tumor types. IBI343 is being...

WASHINGTON--(BUSINESS WIRE)--Rural Healthcare Safety Net Providers Appeal to Congress to Protect 340B...

COLLEYVILLE, Texas--(BUSINESS WIRE)--Bone Solutions Inc., a Colleyville-based orthobiologics company specializing in magnesium-based technologies, announced that the U.S. Food and Drug Administration (FDA) has granted pediatric clearance for its Mg OSTEOCRETE and Mg OSTEOINJECT products. The clearance allows use of the technologies in pediatric patients aged six years and older. This expanded indication highlights the adaptability of Bone Solutions’ proprietary magnesium-based platform, particu...

LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced a proposed underwritten public offering of its Class A common stock (the “Offering”). In addition, Owlet intends to grant the underwriters a 30-day option to purchase additional shares of its Class A common stock in an amount up to 15% of the shares offered in the Offering, at the public offering price per share less underwriting discounts and commissions. Al...

ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. www.bioqual.com BIOQ(Pink Limited): Three Months Ended August 31,   2025   2024   Revenue $ 9,855,399   $ 11,770,482     Loss Before Income Tax $ (343,432 ) $ (931,825 )   Net Loss $ (248,832 ) $ (675,325 )   Basic Earnings per Share of Common Stock $ (0.28 ) $ (0.76 )   Diluted Earnings per Share of Common Stock $ (0.28 ) $ (0.76 )   Weighted Average             Number of Shares Outstanding             For Basic Earnings Per Share   894,416     89...